MARCH 15
MARCH 5
FEBRUARY 24
JANUARY 21
DECEMBER 2
DECEMBER 1
World’s Leading Life Science Companies Now Enrolling COMMUNITY, A Global Platform Trial For Hospitalized Patients with COVID-19
OCTOBER 29
Takeda Expands COVID-19 Vaccine Supply in Japan Through Partnership with Moderna and Government of Japan
OCTOBER 9
OCTOBER 1
19 Organizations from the Healthcare Community Unite to Form COVID-19 Testing Industry Consortium
AUGUST 7
Novavax and Takeda Announce Collaboration for Novavax’ COVID-19 Vaccine Candidate in Japan
AUGUST 3
Members of the COVID R&D Alliance and Quantum Leap Healthcare Collaborative Enroll First Patients in I-SPY COVID Trial
MAY 26
Racing Against Time, Medical Researchers, Life Science Companies and COVID-19 Survivors Launch National Campaign to Drive Blood Plasma Donation
MAY 7
CoVIg-19 Plasma Alliance Builds Strong Momentum Through Expanded Membership and Clinical Trial Collaboration
APRIL 6
Global Plasma Leaders Collaborate to Accelerate Development of Potential COVID-19 Hyperimmune Therapy
MARCH 25
Takeda Research & Development and COVID-19
MARCH 23
Coronavirus and Product Supply
MARCH 4
Takeda Initiates Development of a Plasma-Derived Therapy for COVID-19